Malvern Panalytical to Acquire Micromeritics

Endpoints NewsModerna in talks with FDA over Phase 4 Covid vaccine data

Endpoints NewsFDA approves Pfizer and Arvinas' breast cancer drug despite underwhelming data

Endpoints NewsAmgen launches late-stage obesity trial in patients who switch from rival drugs

FierceBiotech‘M&A used to be the only way to go’: Why Seaport’s CEO opted for route to upsized $255M IPO

BioWorldMoney raised by biopharma

BioWorldBiopharma money raised: Jan. 1-April 30, 2026

Endpoints NewsQ&A: Seaport CEO and CSO on learning from Karuna and the future of CNS research

BioPharma DiveSummit’s ‘self-inflicted’ stumble; Esperion’s take-private deal

BioPharma DiveModerna sees revenue bump from international COVID vaccine sales

Endpoints NewsSamsung Biologics workers begin five-day strike over wage disputes

FierceBiotechSummit's PD-1xVEGF interim trial miss surprises analysts, shares tumble

Endpoints NewsAcelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from China